Ohio is third state to fund Pear’s digital therapeutics to tackle addiction
pharmaphorum
APRIL 23, 2021
The company has been pushing for more reimbursement of its three marketed DTx products in the US following a first FDA approval in 2017. Pear noted that the grant comes at a time when many communities are seeing increased demand for behavioural health and recovery services amid the ongoing coronavirus pandemic.
62 
Let's personalize your content